US FDA moves to tighten premarket requirements for infusion pumps
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration is moving to establish additional premarket requirements for infusion pumps, as part of its new initiative to address safety problems associated with the devices1.